• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of HIV replication by proteasome degradation of Vif

Research Project

Project/Area Number 15590420
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Virology
Research InstitutionThe University of Tokushima

Principal Investigator

FUJITA Mikako  The University of Tokushima, Graduate School Institute of Health Biosciences, Assistant Professor, 大学院・ヘルスバイオサイエンス研究部, 助手 (00322256)

Co-Investigator(Kenkyū-buntansha) ADACHI Akio  The University of Tokushima, Graduate School Institute of Health Biosciences, Professor, 大学院・ヘルスバイオサイエンス研究部, 教授 (90127043)
Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2005: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2004: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsHIV-1 / accessory protein / Vif / proteasome degradation / viral replication / ubiquitination / Cullin / lysine / アルギニン
Research Abstract

An objective of this study is to elucidate regulation of HIV-1 replication by proteasome-degradation of accessory protein Vif. We have been trying to reveal (1)mechanism of the degradation (2)regulation mechanism of magnitude of the degradation (3)biological significance of the degradation on viral replication, and gotten the following results.
(1)Proteasome degradation of Vif was analyzed biochemically by pulse/chase experiments. Two forms of Vif, cytosolic and cytoskeletal, have been known. Cytoskeletal Vif was found to be more stable than soluble cytosolic Vif, and accumulate with time. The degradation characteristics of Vif were cell type-independent and observed in both non-permissive and permissive cells. Comparative stability analysis of the four HIV-1 accessory proteins were performed. Vif was unique in its short half-life and in the degradation. We monitored Vif ubiquitination by immunoprecipitation/Western blotting system. Futhermore, interaction of Vif with Cullin was observed by immunoprecipitation, suggesting the possibility that Cullin works as ubiquitin ligase. (2)Characterization of a series of vif deletion mutants showed that amino acids predicted to be important for formation of β-strand structures (amino acid nos.63-70 and 86-89) were critical for maintaining a normal expression level of Vif and for viral infectivity. (3)Vif mutant, in which all 16 lysines were changed to arginines, was found to be extremely high expression level compared with wild type, and not to confer replication ability on virus. However, we showed that the lack of function was caused by the critical role of 22^<nd> and 26^<th> lysines on viral infectivity, suggesting that arginine mutants are not useful to elucidate biological significance of the degradation on viral replication.

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • Research Products

    (20 results)

All 2005 2004 Other

All Journal Article (14 results) Publications (6 results)

  • [Journal Article] Unique characteristics of HIV-1 Vif expression2005

    • Author(s)
      Wang, H.
    • Journal Title

      Microbes and Infection 7

      Pages: 385-390

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Unique characteristics of HIV-1 Vif expression.2005

    • Author(s)
      Wang, H., Sakurai, A., Khamsri, B., Uchiyama, T., Gu, H., Adachi, A., Fujita, M.
    • Journal Title

      Microbes and Infection 7

      Pages: 385-390

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] High-level expression of Human Immunodeficiency Virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/NC processing site2004

    • Author(s)
      Akira, H.
    • Journal Title

      Journal of Bioligical Chemistry 279

      Pages: 12355-12362

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS2004

    • Author(s)
      Sakurai, A
    • Journal Title

      Microbes and Infection 6

      Pages: 799-805

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome-degradation2004

    • Author(s)
      Fujita, M.
    • Journal Title

      Microbes and Infection 6

      Pages: 791-798

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] High-level expression of Human Immunodeficiency Virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/NC processing site.2004

    • Author(s)
      Akari, H., Fujita, M., Kao, S., Khan, M., A., Shehu-Xhilaga, M., Adachi, A., Strebel, K.
    • Journal Title

      Journal of Biological Chemistry 279

      Pages: 12355-12362

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS.2004

    • Author(s)
      Sakurai, A., Jere, A., Yoshida, A., Yamada, T., Iwamoto, A., Adachi, A., Fujita, M.
    • Journal Title

      Microbes and Infection 6

      Pages: 799-805

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome-degradation.2004

    • Author(s)
      Fujita, M., Akari, H., Sakurai, A., Yoshida, A., Chiba, T., Tanaka, K, Strebel, K., Adachi, A.
    • Journal Title

      Microbes and Infection 6

      Pages: 791-798

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome-degradation.2004

    • Author(s)
      Fujita, M.
    • Journal Title

      Microbes and Infection 6

      Pages: 791-798

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS.2004

    • Author(s)
      Sakurai, A.
    • Journal Title

      Microbes and Infection 6

      Pages: 799-805

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon.2004

    • Author(s)
      Piroozmand, A.
    • Journal Title

      International Journal of Molecular Medicine 14

      Pages: 641-645

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Determination of HIV-1 infectivity by lymphocytic cell lines with integrated luciferase gene.2004

    • Author(s)
      Nagao, T.
    • Journal Title

      International Journal of Molecular Medicine 14

      Pages: 1073-1076

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Generation and characterization of HIV-1 clones chimeric for subtypes B and C nef.2004

    • Author(s)
      Jere, A.
    • Journal Title

      International Journal of Molecular Medicine 14

      Pages: 1087-1090

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Unique characteristics of HIV-1 Vif expression.

    • Author(s)
      Wang, H.
    • Journal Title

      Microbes and Infection (in press)

    • Related Report
      2004 Annual Research Report
  • [Publications] Fujita, M.: "Amino acid residues 88 and 89 in the central hydorophilic region of human immunodeficiency virus type 1 Vif are critical for viral【triple bond】"Journal of Virology. 77. 1626-1632 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Fujita, M.: "Susceptibility of HVS-immortalized lymphocytic HSC-F cells to various strains and mutants of HIV/SIV"International Journal of Molecular Medicine. 11. 641-644 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ueno, F.: "Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells"Microbes and Infection. 5. 387-395 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Akari, H.: "High level expression of Human Immunodeficiency Virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing 【triple bond】"Journal of Biological Chemistry. 279. 12355-12362 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Fujita, M.: "Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome-degradation"Microbes and Infection. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Sakurai, A.: "Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS"Microbes and Infection. (in press).

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi